SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Manny Gugliuzza who wrote (412)5/13/1998 11:31:00 PM
From: jake burns  Read Replies (1) of 1510
 
I sat in on the presentation before Prudential's folks, and was heartened by Dr. Carlo's speech. There is no bad news on the horizon, in my opinion. They expect to have 2 partnerships completed this year, and have big pharmaceutical companies coming to them about Remune. Whether or not they partner it out hasn't been decided. The Remune trial will not be stopped early; it will continue through March, 1999. And, the management is excited about early multiple sclerosis data. They'll continue tests after money is infused via corporate partnerships in other areas. So, it's all good news. I wouldn't play options, cause I don't think one can predict when the big money will flow in. Good luck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News